Keyphrases
Methylglyoxal
100%
Hepatic Disease
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
66%
Hepatocytes
55%
Glyoxalase
33%
Endogenous Hydrogen Sulfide
33%
Hepatotoxic Effect
33%
Liver Disease
22%
Aging Effect
22%
Type 2 Diabetic
22%
Etravirine
11%
In Vitro Comparison
11%
Age-related Risk
11%
Synergize
11%
Pathogenic Mechanism
11%
Cardiomyocytes
11%
Cell Function
11%
HepG2 Cells
11%
Metabolic Enzymes
11%
Liver
11%
Gaseous Transmitters
11%
Saturated Fatty Acids
11%
Diabetes
11%
Age-related Changes
11%
Free Fatty Acids
11%
Developed Countries
11%
Palmitic Acid
11%
Efavirenz
11%
Induced Effect
11%
Pathological Role
11%
Type 2 Diabetes Mellitus (T2DM)
11%
H9c2
11%
Inflammation
11%
Hepatocyte Function
11%
Pharmacology, Toxicology and Pharmaceutical Science
Methylglyoxal
100%
Liver Disease
100%
Nonalcoholic Fatty Liver
66%
Hepatotoxicity
33%
Glyoxalase
33%
Diabetes Mellitus
22%
Hydrogen Sulfide
22%
Sulfur 35
22%
Inflammation
11%
Palmitic Acid
11%
Fatty Acid
11%
Non Insulin Dependent Diabetes Mellitus
11%
Etravirine
11%
Efavirenz
11%
Saturated Fatty Acid
11%
Diseases
11%